Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana (Q40797865)

23 September 2017

title

Isoniazid-associated hepatitis and antiretroviral drugs during tuberculosis prophylaxis in hiv-infected adults in Botswana (English)

1 reference

23 September 2017

0 references

anti-retroviral agent

0 references

0 references

0 references

Zegabriel Tedla

1

0 references

Crandall Peeler

object named as

Crandall Peeler

3

0 references

author name string

Samba Nyirenda

2

1 reference

23 September 2017

Tefera Agizew

4

1 reference

23 September 2017

Thabisa Sibanda

5

1 reference

23 September 2017

Oaitse Motsamai

6

1 reference

23 September 2017

Andrew Vernon

7

1 reference

23 September 2017

Charles D Wells

8

1 reference

23 September 2017

Taraz Samandari

9

1 reference

23 September 2017

language of work or name

English

0 references

publication date

8 April 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

23 September 2017

published in

1 reference

23 September 2017

volume

182

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

278-285

1 reference

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Scaling up ART treatment capacity: lessons learned from South Africa, Zimbabwe, and Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Antiretroviral therapy-associated toxicities in the resource-poor world: the challenge of a limited formulary

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Prevalence of hepatitis-B surface antigen among blood donors and human immunodeficiency virus-infected patients in Jos, Nigeria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

The association between HIV infection and alcohol use: a systematic review and meta-analysis of African studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

HIV risk factors among patients with tuberculosis--Botswana 1999.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Toxic effects of isoniazid in tuberculosis chemoprophylaxis. Role of biochemical monitoring in 1,000 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Severe acetaminophen toxicity in a patient receiving isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Isoniazid-associated hepatitis deaths: a review of available information

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Isoniazid toxicity in health care workers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Twenty isoniazid-associated deaths in one state

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

An official ATS statement: hepatotoxicity of antituberculosis therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Screening for problem drinking: comparison of CAGE and AUDIT. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

A population-based study on alcohol and high-risk sexual behaviors in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Screening, Brief Intervention, and Referral to Treatment (SBIRT): toward a public health approach to the management of substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Reactogenicity and immunogenicity of combined vaccines for bacteraemic diseases caused by Haemophilus influenzae type b, meningococci and pneumococci in 24-month-old children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

HIV, hepatitis B and hepatitis C coinfection in Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Prevalence and interaction of hepatitis B and latent tuberculosis in Vietnamese immigrants to the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Use of traditional medicine by HIV-infected individuals in South Africa in the era of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

The toxicity of Callilepis laureola, a South African traditional herbal medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Drug-related hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Viral hepatitis in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Isoniazid preventive therapy for tuberculosis in HIV-1-infected adults: results of a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Use of Isoniazid for Latent Tuberculosis Infection in a Public Health Clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

Rifampin and pyrazinamide vs isoniazid for prevention of tuberculosis in HIV-infected persons: an international randomized trial. Terry Beirn Community Programs for Clinical Research on AIDS, the Adult AIDS Clinical Trials Group, the Pan American He

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200911-1783OC

10.1164/RCCM.200911-1783OC

21 January 2018

Identifiers

DOI

1 reference

23 September 2017

1 reference